MolNFT v1 · #154835 · protein
Thrb mutation with a novel agonist
6KNU · Thyroid hormone receptor beta: “Thrb mutation with a novel agonist”. X-ray diffraction, 1 ligand (8HO), 3 pockets (best druggability 0.83). MolNFT v1 #154835 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 6KNU
- Type
- protein
- Length
- 251 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Thyroid hormone receptor beta; Nuclear receptor coactivator 2
- UniProt
- P10828, Q15596
- Ligands
- 8HO
- Pockets
- 3 · best druggability 0.83
Structure
x-ray diffraction · 2 distinct chains · 63% helix, 4% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Thyroid hormone receptor beta | protein | 242 | 62% helix, 5% strand | P10828 |
| C | Nuclear receptor coactivator 2 | protein | 9 | 67% helix, 0% strand | Q15596 |
Ligands and binding sites
- 8HO · 2-[(1-methyl-4-oxidanyl-7-phenoxy-isoquinolin-3-yl) carbonylamino]ethanoic acid · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 218 | 0.83 | 0.96 | 32 | 8HO |
| 2 | 97 | 0.38 | 0.75 | 18 | empty |
| 3 | 74 | 0.37 | 0.77 | 15 | empty |
Interfaces
1 interface between chains.
- A–C · 518 Ų buried · 7 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P10828
- Every structure of UniProt Q15596
- Elsewhere: RCSB PDB 6KNU · PDBe 6KNU · UniProt P10828 · UniProt Q15596
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.